Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$448K Sell
3,793
-1,039
-22% -$120K 0.02% 705
2026
Q1
$577K Sell
4,832
-18
-0.4% -$2.36K 0.03% 518
2025
Q4
$660K Buy
4,850
+42
+0.9% +$6.04K 0.03% 432
2025
Q3
$709K Buy
4,808
+625
+15% +$86.7K 0.04% 397
2025
Q2
$541K Sell
4,183
-58
-1% -$7.02K 0.03% 453
2025
Q1
$507K Buy
4,241
+956
+29% +$118K 0.04% 411
2024
Q4
$381K Sell
3,285
-407
-11% -$51.5K 0.03% 454
2024
Q3
$499K Buy
3,692
+894
+32% +$120K 0.05% 335
2024
Q2
$379K Buy
2,798
+1,278
+84% +$174K 0.05% 331
2024
Q1
$196K Buy
1,520
+264
+21% +$31.9K 0.04% 392
2023
Q4
$141K Buy
+1,256
New +$125K 0.04% 415

Other funds holding XYL

GAMMA Investing's XYL Position: Q2 2026 in Review

GAMMA Investing reduced its Xylem (XYL) stake by 22% in Q2 2026, selling an estimated $120K and leaving 3,793 shares worth $448K. The position accounts for 0.02% of the portfolio, ranked #705.

GAMMA Investing first reported a position in XYL in Q4 2023 and has held it in 11 quarters since. The position peaked at $709K in Q3 2025. 213 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • GAMMA Investing held 3,793 shares of Xylem worth $448K as of Q2 2026.
  • GAMMA Investing sold 1,039 Xylem shares in Q2 2026, an estimated $120K.
  • Xylem made up 0.02% of GAMMA Investing's portfolio in Q2 2026, its #705 holding.
  • GAMMA Investing first reported a position in Xylem in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Xylem position peaked at $709K in Q3 2025.
  • 213 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.